The prevalence of thyroid function test abnormalities and serum thyroid autoantibodies in vitiligo and alopecia areata patients in Saudi Arabian population


  • Renad Alnemari King Abdulaziz University, Jeddah, Saudi Arabia
  • Awadh Alamri Department of Dermatology, King Saud Medical City, Jeddah, Saudi Arabia



Vitiligo, AA, Thyroid disease, Thyroid autoantibody, Saudi Arabia


Background: Alopecia areata (AA) and vitiligo are immune-mediated inflammatory diseases characterized by hair loss and depigmented macules, respectively. It is often associated with other autoimmune conditions especially with autoimmune thyroid disorders indicating a potential role of autoimmunity in its development.

Methods: A 222 patients, 113 AA and 109 vitiligo diagnosed, were retrospectively reviewed. We analyzed TG-Ab, TPO-Ab, Thyroid function tests (free T3, free T4, and TSH) in all patients.

Results: In vitiligo patients, 11% (n=12) had elevated levels of anti-TG levels and 26.6% (n=29) had elevated levels of anti-TPO, Thyroid hormonal abnormalities were found in 15.6% (n=17) of vitiligo patients, and fT4 was elevated in 1.83% (n=2) patients. Within AA patients, 15.9% (n=18) had anti-TG elevation and 23.9% (n=27) had anti-TPO elevation, thyroid hormonal abnormalities were found in 16.8% (n=19), and fT4 was high in 0.88% (n=1) patient. No significant difference was found between the two groups for all measured parameters. No statistically significant correlation between the gender of the patients and the diagnosis, thyroid hormonal test, and thyroid autoantibody levels could be detected (p>0.05)

Conclusions: In our study, impaired thyroid functions and thyroid autoantibodies in vitiligo and AA patients were identified at similar rates of the previous studies. Moreover, we could not find differences in comparison to other ethnicities.


Wasserman D, Guzman‐Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol. 2007;46(2):121-31.

Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton III LJ. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. InMayo Clinic Proceedings 1995;70(7):628-33.

Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Investigation. 2007;117(8):2019-27.

Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya‐Anunt SU. Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol. 1994;33(9):632-3.

Sharma VK, Dawn G, Kumar B. Profile of alopecia areata in Northern India. Int J Dermatol. 1996;35(1):22-7.

Kovacs SO. Vitiligo. J Am Acad Dermatol. 1998;38(5 Pt 1):647-66.

Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206-12.

Howitz J, Brodthagen H, Schwartz M, Thomsen K. Prevalence of vitiligo: epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol. 1977;113(1):47-52.

Gauthier Y, Andre MC, Taïeb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res. 2003;16(4):322-32.

Mohammed GF, Gomaa AH, Al-Dhubaibi MS. Highlights in pathogenesis of vitiligo. World J Clin Cases. 2015;3(3):221.

Yang Y, Huang G, Yan X, Qing Z. Clinical analysis of thyroglobulin antibody and thyroid peroxidase antibody and their association with vitiligo. Indian J Dermatol. 2014;59(4):357.

Uncu S, Yaylı S, Bahadır S, Ökten A, Alpay K. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Int J Dermatol. 2011;50(2):175-9.

Saylam Kurtipek G, Cihan FG, Erayman Demirbaş Ş, Ataseven A. The frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients. BioMed Res Int. 2015;2015.

Bakry OA, Basha MA, El Shafiee MK, Shehata WA. Thyroid disorders associated with alopecia areata in Egyptian patients. Indian J Dermatol. 2014;59(1):49.

Seyrafi H, Akhiani M, Abbasi H, Mirpour S, Gholamrezanezhad A. Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol. 2005;5:1-5.

Heydarian P, Azizi F. Thyroid dysfunction and autoantibodies 10 years after implementation of universal salt iodization: Tehran Thyroid Study. Iranian J Endocrinol Metabol. 2002;4(4):229-41.

Shellow WV, Edwards JE, Koo JY. Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol. 1992;31(3):186-9.

Cunliffe WJ, Hall R, Stevenson CJ, Weightman D. Alopecia areata thyroid disease and autoimmunity. Bri J Dermatol. 1969;81(12):877-81.

Muller SA, Winkelmann RK. Alopecia areata: an evaluation of 736 patients. Arch Dermatol. 1963;88(3):290-7.

Sweitzer SE. Alopecia areata in an infant. Arch Dermatol Syphilol. 1947;55(1):143.

Thomas AE, Kadyan RS. Alopecia areata and autoimmunity: a clinical study. Indian J Dermatol. 2008;53(2):70.

Kasumagić-Halilović E. Thyroid autoimmunity in patients with alopecia areata. Acta Dermatovenerologica Croatica. 2008;16(3).

Gönül M, Gül Ü, Piskin E, Çakmak SK, Soylu S, Kiliç A, Biyikli Z. Alopesi Areatali Hastalarin Geriye Dönük Degerlendirilmesi/Retrospective Evaluation of Alopecia Areata Patients. Turk Dermatoloji Dergisi. 2011;5(2):43.

Korkij W, Solatani K, Simjee S, Marcincin PG, Chuang TY. Tissue‐specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study. J Cutaneous Pathol. 1984;11(6):522-30.

Kurtev A, Iliev E. Thyroid autoimmunity in children and adolescents with alopecia areata. Int J Dermatol. 2005;44(6):457-61.

Kasumagic-Halilovic E, Prohic A, Begovic B, Ovcina-Kurtovic N. Association between vitiligo and thyroid autoimmunity. J Thyroid Res. 2011;2011.

Moradi S, Ghafarpoor G. Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo. Indian J Dermatol. 2008;53(1):9-11.

Dave S, D'Souza M, Thappa DM, Reddy KS, Bobby Z. High frequency of thyroid dysfunction in Indian patients. Indian J Dermatol. 2003;48(2):63-72.






Original Research Articles